Rechallenge of clozapine in a patient with a history of clozapine-induced myocarditis

Koparal, BUKET; KÜÇÜKKARAPINAR, MELİKE; EKMEKCİ ERTEK, İREM

doi:10.14744/dajpns.2019.00038

Rechallenge of clozapine in a patient with a history of clozapine-induced myocarditis

Atıf İçin Kopyala

Koparal B., KÜÇÜKKARAPINAR M., EKMEKCİ ERTEK İ.

DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, cilt.32, sa.3, ss.275-278, 2019 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 32 Sayı: 3
Basım Tarihi: 2019
Doi Numarası: 10.14744/dajpns.2019.00038
Dergi Adı: DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.275-278
Gazi Üniversitesi Adresli: Evet

Özet

Clozapine is the only antipsychotic with proven efficacy in treatment-resistant schizophrenia, but some life-threatening side effects limit its use. Here we report a patient with clozapine-induced myocarditis and successful rechallenge. The patient still uses clozapine and has not developed myocarditis over 36 months of observation. It may be possible to use clozapine even after myocarditis and thus improve symptoms and functionality of schizophrenia patients.